PepGen: Stock Soars On DM1 Data, But Caution Warranted On Small Sample Sizes

🇺🇸 Seeking Alpha (US) —

AI Summary

PepGen shares surged after the company reported data related to DM1, though the article cautions that the results come from a small sample. The headline signals investor interest alongside uncertainty about the evidence.

Markets Health PepGen DM1 clinical data stock surge sample size biotechnology

Read original source →